Fulcrum Therapeutics Inc (FULC)
7.15
-0.27
(-3.64%)
USD |
NASDAQ |
Apr 17, 16:00
7.15
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Price to Book Value: 1.883 for April 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 16, 2024 | 1.954 |
| April 15, 2024 | 1.938 |
| April 12, 2024 | 1.975 |
| April 11, 2024 | 2.057 |
| April 10, 2024 | 2.083 |
| April 09, 2024 | 2.225 |
| April 08, 2024 | 2.225 |
| April 05, 2024 | 2.244 |
| April 04, 2024 | 2.373 |
| April 03, 2024 | 2.404 |
| April 02, 2024 | 2.388 |
| April 01, 2024 | 2.452 |
| March 28, 2024 | 2.486 |
| March 27, 2024 | 2.491 |
| March 26, 2024 | 2.404 |
| March 25, 2024 | 2.483 |
| March 22, 2024 | 2.546 |
| March 21, 2024 | 2.578 |
| March 20, 2024 | 2.565 |
| March 19, 2024 | 2.660 |
| March 18, 2024 | 2.665 |
| March 15, 2024 | 2.992 |
| March 14, 2024 | 2.944 |
| March 13, 2024 | 2.992 |
| March 12, 2024 | 2.873 |
| Date | Value |
|---|---|
| March 11, 2024 | 2.970 |
| March 08, 2024 | 2.918 |
| March 07, 2024 | 2.978 |
| March 06, 2024 | 3.160 |
| March 05, 2024 | 2.886 |
| March 04, 2024 | 2.984 |
| March 01, 2024 | 2.894 |
| February 29, 2024 | 2.689 |
| February 28, 2024 | 2.718 |
| February 27, 2024 | 2.681 |
| February 26, 2024 | 2.562 |
| February 23, 2024 | 2.528 |
| February 22, 2024 | 2.515 |
| February 21, 2024 | 2.515 |
| February 20, 2024 | 2.499 |
| February 16, 2024 | 2.538 |
| February 15, 2024 | 2.475 |
| February 14, 2024 | 2.393 |
| February 13, 2024 | 2.356 |
| February 12, 2024 | 2.435 |
| February 09, 2024 | 2.330 |
| February 08, 2024 | 2.146 |
| February 07, 2024 | 2.103 |
| February 06, 2024 | 2.185 |
| February 05, 2024 | 2.093 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4711
Minimum
Apr 12 2023
11.25
Maximum
Sep 20 2021
2.786
Average
2.487
Median
Aug 19 2022
Price to Book Value Benchmarks
| Pfizer Inc | 1.612 |
| NovaBay Pharmaceuticals Inc | 1.812 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7142 |
| Theriva Biologics Inc | 0.1951 |
Price to Book Value Related Metrics
| PS Ratio | 156.27 |
| Price | 7.15 |
| Earnings Yield | -22.10% |
| Market Cap | 442.84M |